Company intelligence / Profile preview

Seqalis

Gosselies, Wallonia, Belgiumseqalis.com ↗

Ownership: Private
Development stage: Other

Overview

Seqalis provides advanced laboratory testing and analytical services in anatomical pathology, cytogenomics, molecular biology, NGS sequencing, and immune monitoring. It plays a key role as a service partner for life science innovation projects including major international cancer research initiatives like the AURORA project for breast cancer. The company has launched platforms such as quantitative TCR sequencing to support personalized medicine efforts.

Therapeutic areas: OncologyOther
Modalities: Next Generation SequencingImmunological monitoringCytogenomics assaysMolecular biology assays
Industry: Molecular Diagnostics

Partnerships

Breast International Group (BIG) – AURORA project participation

Beyond the preview

Go deeper on Seqalis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seqalis.

Explore the full profile